KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Change in Cash: 2009-2024

Historic Change in Cash for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to $123.5 million.

  • Pacira BioSciences' Change in Cash fell 13952.85% to -$152.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$98.4 million, marking a year-over-year decrease of 166.99%. This contributed to the annual value of $123.5 million for FY2024, which is 151.18% up from last year.
  • As of FY2024, Pacira BioSciences' Change in Cash stood at $123.5 million, which was up 151.18% from $49.2 million recorded in FY2023.
  • In the past 5 years, Pacira BioSciences' Change in Cash registered a high of $485.6 million during FY2021, and its lowest value of -$481.4 million during FY2022.
  • In the last 3 years, Pacira BioSciences' Change in Cash had a median value of $49.2 million in 2023 and averaged -$102.9 million.
  • Its Change in Cash has fluctuated over the past 5 years, first surged by 2,134.90% in 2021, then slumped by 199.14% in 2022.
  • Over the past 5 years, Pacira BioSciences' Change in Cash (Yearly) stood at $21.7 million in 2020, then soared by 2,134.90% to $485.6 million in 2021, then crashed by 199.14% to -$481.4 million in 2022, then skyrocketed by 110.21% to $49.2 million in 2023, then skyrocketed by 151.18% to $123.5 million in 2024.